Coping with toxicities of docetaxel (Taxotere)

Ann Oncol. 1993 Aug;4(7):610-1. doi: 10.1093/oxfordjournals.annonc.a058599.

Abstract

Background: In phase II studies of the EORTC-ECTG, acute hypersensitivity reaction, edema and skin toxicity were important side effects of docetaxel (TaxotereTM).

Patients and methods: Fifty patients with solid tumors were treated with docetaxel at the University Hospital of Antwerp. Of these, 28% developed an acute hypersensitivity reaction and 20% edema. Twelve and three hours before the next docetaxel administrations those with the acute hypersensitivity reaction were subsequently pretreated orally with 32 mg of methylprednisolone, 10 mg of cetirizine and 1 mg of ketotifen.

Conclusions: The acute hypersensitivity reaction could be completely blocked in all but in 1 of 14 patients, and this pretreatment schedule had an important prophylactic effect on edema formation. Skin toxicity was successfully treated with an ointment of glycerin and chlorhexidine.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Cetirizine / therapeutic use
  • Docetaxel
  • Drug Hypersensitivity / prevention & control*
  • Edema / chemically induced
  • Humans
  • Ketotifen / therapeutic use
  • Methylprednisolone / therapeutic use
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Paclitaxel / analogs & derivatives*
  • Skin Diseases / chemically induced
  • Taxoids*

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel
  • Ketotifen
  • Methylprednisolone
  • Cetirizine